Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC episode artwork

EPISODE · Feb 21, 2019 · 3 MIN

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC

from Oncology Learning Network · host HMP Global

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC by HMP Global

Episode metadata supplied by the publisher feed · Published Feb 21, 2019

Embed this episode

Ready to play

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC

0:00 3:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 3 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on February 21, 2019.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!